Armata Pharmaceuticals (ARMP) Institutional Ownership $1.49 -0.10 (-6.29%) As of 02:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Armata Pharmaceuticals (NYSEAMERICAN:ARMP)CurrentInstitutional OwnershipPercentage3.57%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)2 Get ARMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Armata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARMP Institutional Buying and Selling by Quarter Armata Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Bridgeway Capital Management LLC69,682$129K0.0%-7.6%0.193% 2/13/2025Renaissance Technologies LLC40,291$75K0.0%-13.3%0.111% 4/18/2024 SeaCrest Wealth Management LLC32,777$137K0.0%+80.8%0.091% 11/12/2021Renaissance Technologies LLC106,092$384K0.0%-9.1%0.425% 11/9/2021BlackRock Inc.20,571$74K0.0%+928.0%0.082% 11/8/2021Synovus Financial Corp48,060$174K0.0%+108.4%0.193% 8/17/2021Bridgeway Capital Management LLC113,400$450K0.0%+134.3%0.455% 8/13/2021Renaissance Technologies LLC116,696$463K0.0%-5.8%0.468% 8/13/2021Vanguard Group Inc.167,378$665K0.0%+121.4%0.671% 5/21/2021Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/18/2021Millennium Management LLC15,401$74K0.0%N/A0.062% 5/18/2021Loomis Sayles & Co. L P129,956$621K0.0%N/A0.521% 5/18/2021Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/13/2021Renaissance Technologies LLC123,816$592K0.0%+25.1%0.496% 5/13/2021Edgewood Management LLC50,000$239K0.0%+25.0%0.200% 5/12/2021Geode Capital Management LLC10,188$48K0.0%N/A0.041% 5/12/2021UBS Group AG6,017$29K0.0%+73.4%0.024% 5/7/2021BlackRock Inc.40,448$194K0.0%+12.4%0.162% (Data available from 1/1/2016 forward) ARMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARMP shares? During the previous two years, the following institutional investors and hedge funds held shares of Armata Pharmaceuticals shares: SeaCrest Wealth Management LLC ($137K), and Bridgeway Capital Management LLC ($129K), Renaissance Technologies LLC ($75K).Learn more on ARMP's institutional investors. What percentage of Armata Pharmaceuticals stock is owned by institutional investors? 3.57% of Armata Pharmaceuticals stock is owned by institutional investors. Learn more on ARMP's institutional investor holdings. Which institutional investors have been buying Armata Pharmaceuticals stock? The following institutional investors have purchased Armata Pharmaceuticals stock in the last 24 months: SeaCrest Wealth Management LLC ($14.65K). How much institutional buying is happening at Armata Pharmaceuticals? Institutional investors have bought a total of 14,647 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Armata Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Armata Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($6.21K), and Bridgeway Capital Management LLC ($5.70K). How much institutional selling is happening at Armata Pharmaceuticals? Institutional investors have sold a total of 11,905 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies Annexon Institutional Ownership INmune Bio Institutional Ownership Canopy Growth Institutional Ownership Y-mAbs Therapeutics Institutional Ownership Voyager Therapeutics Institutional Ownership Gossamer Bio Institutional Ownership Kodiak Sciences Institutional Ownership TuHURA Biosciences Institutional Ownership DBV Technologies Institutional Ownership Esperion Therapeutics Institutional Ownership This page (NYSEAMERICAN:ARMP) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Armata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARMP Stock Free ARMP Stock Alerts